Aeroflex Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 14, 2025, 10:09 pm

Quick Insight

Aeroflex Industries Ltd, based in Mumbai, currently trades at ₹182 per share with a market capitalization of ₹2,349 Cr. The stock carries a high P/E ratio of 49.8, indicating potentially overvalued shares. However, strong returns on equity (ROE) at 16.5% and returns on capital employed (ROCE) at 22.2% reflect efficient utilization of resources. The company's operating profit margin (OPM) stands at 19.62%, showing healthy operational efficiency. With a low level of borrowings at ₹1 Cr and a comfortable interest coverage ratio (ICR) of 227.11x, Aeroflex appears financially sound. Despite a high price-to-book value (P/BV) of 6.43x, the substantial reserves of ₹316 Cr provide a cushion. Shareholders' composition reveals a dominant promoter holding of 66.99%, with FIIs at 1.57%, DIIs at 5.66%, and the public at 25.76%. The firm's robust financials and operational performance suggest a well-managed entity poised for potential growth, but investors should closely monitor the valuation multiples for entry points.

Competitors of Aeroflex Industries Ltd

All Competitor Stocks of Aeroflex Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 8:20 am

Below is a detailed analysis of the quarterly data for Aeroflex Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 79.19 Cr.. The value appears to be declining and may need further review. It has decreased from 94.23 Cr. (Mar 2025) to 79.19 Cr., marking a decrease of 15.04 Cr..
• For Expenses, as of Jun 2025, the value is 63.65 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 75.84 Cr. (Mar 2025) to 63.65 Cr., marking a decrease of 12.19 Cr..
• For Operating Profit, as of Jun 2025, the value is 15.54 Cr.. The value appears to be declining and may need further review. It has decreased from 18.39 Cr. (Mar 2025) to 15.54 Cr., marking a decrease of 2.85 Cr..
• For OPM %, as of Jun 2025, the value is 19.62%. The value appears strong and on an upward trend. It has increased from 19.52% (Mar 2025) to 19.62%, marking an increase of 0.10%.
• For Other Income, as of Jun 2025, the value is 0.33 Cr.. The value appears strong and on an upward trend. It has increased from 0.27 Cr. (Mar 2025) to 0.33 Cr., marking an increase of 0.06 Cr..
• For Interest, as of Jun 2025, the value is 0.18 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Mar 2025) to 0.18 Cr., marking an increase of 0.05 Cr..
• For Depreciation, as of Jun 2025, the value is 5.48 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.88 Cr. (Mar 2025) to 5.48 Cr., marking an increase of 1.60 Cr..
• For Profit before tax, as of Jun 2025, the value is 10.21 Cr.. The value appears to be declining and may need further review. It has decreased from 14.65 Cr. (Mar 2025) to 10.21 Cr., marking a decrease of 4.44 Cr..
• For Tax %, as of Jun 2025, the value is 25.27%. The value appears to be increasing, which may not be favorable. It has increased from 24.16% (Mar 2025) to 25.27%, marking an increase of 1.11%.
• For Net Profit, as of Jun 2025, the value is 7.62 Cr.. The value appears to be declining and may need further review. It has decreased from 11.11 Cr. (Mar 2025) to 7.62 Cr., marking a decrease of 3.49 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.59. The value appears to be declining and may need further review. It has decreased from 0.86 (Mar 2025) to 0.59, marking a decrease of 0.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:38 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:58 pm

Below is a detailed analysis of the balance sheet data for Aeroflex Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 26.00 Cr..
• For Reserves, as of Mar 2025, the value is 316.00 Cr.. The value appears strong and on an upward trend. It has increased from 267.00 Cr. (Mar 2024) to 316.00 Cr., marking an increase of 49.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 82.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81.00 Cr. (Mar 2024) to 82.00 Cr., marking an increase of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 424.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 375.00 Cr. (Mar 2024) to 424.00 Cr., marking an increase of 49.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 149.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2024) to 149.00 Cr., marking an increase of 66.00 Cr..
• For CWIP, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 28.00 Cr., marking an increase of 28.00 Cr..
• For Other Assets, as of Mar 2025, the value is 238.00 Cr.. The value appears to be declining and may need further review. It has decreased from 286.00 Cr. (Mar 2024) to 238.00 Cr., marking a decrease of 48.00 Cr..
• For Total Assets, as of Mar 2025, the value is 424.00 Cr.. The value appears strong and on an upward trend. It has increased from 375.00 Cr. (Mar 2024) to 424.00 Cr., marking an increase of 49.00 Cr..

Notably, the Reserves (316.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Aeroflex Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.06. This value is below the healthy minimum of 5. It has increased from 3.39 (Mar 24) to 4.06, marking an increase of 0.67.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.06. This value is below the healthy minimum of 5. It has increased from 3.39 (Mar 24) to 4.06, marking an increase of 0.67.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.93. This value is within the healthy range. It has increased from 3.71 (Mar 24) to 4.93, marking an increase of 1.22.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 26.48. It has increased from 22.67 (Mar 24) to 26.48, marking an increase of 3.81.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 26.48. It has increased from 22.67 (Mar 24) to 26.48, marking an increase of 3.81.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 29.09. It has increased from 24.58 (Mar 24) to 29.09, marking an increase of 4.51.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.31. This value is within the healthy range. It has increased from 5.08 (Mar 24) to 6.31, marking an increase of 1.23.
• For PBIT / Share (Rs.), as of Mar 25, the value is 5.44. This value is within the healthy range. It has increased from 4.59 (Mar 24) to 5.44, marking an increase of 0.85.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.41. This value is within the healthy range. It has increased from 4.43 (Mar 24) to 5.41, marking an increase of 0.98.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.06. This value is within the healthy range. It has increased from 3.23 (Mar 24) to 4.06, marking an increase of 0.83.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.06. This value is within the healthy range. It has increased from 3.23 (Mar 24) to 4.06, marking an increase of 0.83.
• For PBDIT Margin (%), as of Mar 25, the value is 21.68. This value is within the healthy range. It has increased from 20.65 (Mar 24) to 21.68, marking an increase of 1.03.
• For PBIT Margin (%), as of Mar 25, the value is 18.68. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 18.68.
• For PBT Margin (%), as of Mar 25, the value is 18.59. This value is within the healthy range. It has increased from 18.00 (Mar 24) to 18.59, marking an increase of 0.59.
• For Net Profit Margin (%), as of Mar 25, the value is 13.95. This value exceeds the healthy maximum of 10. It has increased from 13.12 (Mar 24) to 13.95, marking an increase of 0.83.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.95. This value is within the healthy range. It has increased from 13.12 (Mar 24) to 13.95, marking an increase of 0.83.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.33. This value is within the healthy range. It has increased from 14.23 (Mar 24) to 15.33, marking an increase of 1.10.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.41. This value is within the healthy range. It has increased from 20.20 (Mar 24) to 20.41, marking an increase of 0.21.
• For Return On Assets (%), as of Mar 25, the value is 12.30. This value is within the healthy range. It has increased from 11.12 (Mar 24) to 12.30, marking an increase of 1.18.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.93. It has decreased from 1.08 (Mar 24) to 0.93, marking a decrease of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has decreased from 3.46 (Mar 24) to 2.91, marking a decrease of 0.55.
• For Quick Ratio (X), as of Mar 25, the value is 2.10. This value exceeds the healthy maximum of 2. It has decreased from 2.73 (Mar 24) to 2.10, marking a decrease of 0.63.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 4. It has decreased from 3.61 (Mar 24) to 3.50, marking a decrease of 0.11.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.47 (Mar 24) to 0.00, marking a decrease of 5.47.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.76 (Mar 24) to 0.00, marking a decrease of 4.76.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.53 (Mar 24) to 0.00, marking a decrease of 94.53.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.24 (Mar 24) to 0.00, marking a decrease of 95.24.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 227.11. This value is within the healthy range. It has increased from 30.70 (Mar 24) to 227.11, marking an increase of 196.41.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 147.18. This value is within the healthy range. It has increased from 20.51 (Mar 24) to 147.18, marking an increase of 126.67.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,174.22. It has increased from 1,465.00 (Mar 24) to 2,174.22, marking an increase of 709.22.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.78. This value exceeds the healthy maximum of 3. It has increased from 4.61 (Mar 24) to 5.78, marking an increase of 1.17.
• For EV / EBITDA (X), as of Mar 25, the value is 26.65. This value exceeds the healthy maximum of 15. It has increased from 22.31 (Mar 24) to 26.65, marking an increase of 4.34.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.85. This value exceeds the healthy maximum of 3. It has increased from 4.94 (Mar 24) to 5.85, marking an increase of 0.91.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 94.52 (Mar 24) to 0.00, marking a decrease of 94.52.
• For Price / BV (X), as of Mar 25, the value is 6.43. This value exceeds the healthy maximum of 3. It has increased from 5.36 (Mar 24) to 6.43, marking an increase of 1.07.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.85. This value exceeds the healthy maximum of 3. It has increased from 4.94 (Mar 24) to 5.85, marking an increase of 0.91.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness